Upper for Lipiodol decided at KRW 190 thousand with obligation of stable supply

Lipiodol, which has recently been suspended in supply, has come to the final decision at the Health Insurance Policy Deliberation Committee after the drug price negotiation with the National Health Insurance Service(NHIS).

According to the decision at the deliberation committee, drug price for Lipiodol was decided at KRW 190 thousand, and several conditions were promised and added, such as obl...